アリゾナ州における血液がんの臨床試験
アリゾナ州内の拠点で、血液がんに関する12件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Arizona Cancer Center at UMC North ( Site 0018), Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Kingman Regional Medical Center, Kingman
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/17更新 · NCT04242095(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Mayo Clinic Arizona, Phoenix
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04996875Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- City of Hope - Phoenix, Goodyear
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/03更新 · NCT04588922Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/20更新 · NCT07007312Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT06001788A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Banner MD Anderson Cancer Center, Gilbert
- Phoenix Children's Hospital, Phoenix
- University of Arizona Medical Center - Tucson, Tucson
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- St. Joseph's Hospital and Medical Center, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT03328078A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Mayo Clinic - Phoenix, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/13更新 · NCT05735184Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
- Mayo Clinic in Arizona, Scottsdale
被験者募集中
18歳以上 · 全性別 · 2026/02/23更新 · NCT02958462A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中観察研究
18歳以上 · 全性別 · 2025/06/25更新 · NCT05768269ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。